当前位置:首页 - 行情中心 - 仁度生物(688193) - 财务分析 - 现金流量表

仁度生物

(688193)

  

流通市值:22.04亿  总市值:22.04亿
流通股本:4006.99万   总股本:4006.99万

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金42,696,759.4202,644,446.67136,587,362.183,942,045.25
  收到的税费返还--4,859.644,859.64
  收到其他与经营活动有关的现金186,150.184,643,813.763,246,369.62,490,300.07
  经营活动现金流入的平衡项目-0.01000
  经营活动现金流入小计42,882,909.57207,288,260.43139,838,591.3486,437,204.96
  购买商品、接受劳务支付的现金10,807,089.4926,753,149.3419,160,845.0510,087,474.93
  支付给职工以及为职工支付的现金17,864,234.476,696,581.2158,802,412.8242,362,599.7
  支付的各项税费6,907,301.4817,735,837.8311,423,288.916,235,130.73
  支付其他与经营活动有关的现金17,430,576.7663,695,619.2144,692,638.7128,793,939.39
  经营活动现金流出小计53,009,202.13184,881,187.59134,079,185.4987,479,144.75
  经营活动产生的现金流量净额-10,126,292.5622,407,072.845,759,405.85-1,041,939.79
二、投资活动产生的现金流量:
  收回投资收到的现金354,184,4602,063,000,0001,393,000,0001,125,000,000
  取得投资收益收到的现金3,362,434.7311,066,403.625,789,824.724,651,748.21
  处置固定资产、无形资产和其他长期资产收回的现金净额-209,569.424,600-
  投资活动现金流入小计357,546,894.732,074,275,973.041,398,794,424.721,129,651,748.21
  购建固定资产、无形资产和其他长期资产支付的现金-7,074,497.891,500,981.63906,926.83
  投资支付的现金350,000,0002,243,000,0001,513,969,827.681,155,516,052.62
  投资活动现金流出小计350,000,0002,250,074,497.891,515,470,809.311,156,422,979.45
  投资活动产生的现金流量净额7,546,894.73-175,798,524.85-116,676,384.59-26,771,231.24
三、筹资活动产生的现金流量:
  吸收投资收到的现金-2,627,1122,627,112-
  收到其他与筹资活动有关的现金--65,256-
  筹资活动现金流入平衡项目-00-
  筹资活动现金流入小计-2,627,1122,692,368-
  分配股利、利润或偿付利息支付的现金-9,687,623.53,870,857.23,870,857.2
  支付其他与筹资活动有关的现金925,389.142,479,842.182,128,872.751,490,213.64
  筹资活动现金流出小计925,389.1412,167,465.685,999,729.955,361,070.84
  筹资活动产生的现金流量净额-925,389.14-9,540,353.68-3,307,361.95-5,361,070.84
四、汇率变动对现金及现金等价物的影响-154,945.64-1,211,864.5847,065.72469,801.83
  现金及现金等价物净增加额平衡项目0.01000
五、现金及现金等价物净增加额-3,659,732.6-164,143,670.19-113,377,274.97-32,704,440.04
  加:期初现金及现金等价物余额97,434,315.63261,577,985.82261,577,985.82261,577,985.82
  期末现金及现金等价物余额93,774,583.0397,434,315.63148,200,710.85228,873,545.78
补充资料:
  净利润-10,087,386.2-2,037,965.98
  资产减值准备-1,947,447.67-905,130
  固定资产和投资性房地产折旧-13,478,648.43-7,028,991.8
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-13,478,648.43-7,028,991.8
  无形资产摊销-202,737.81-111,110.89
  长期待摊费用摊销-2,883,959.08-1,499,197.46
  处置固定资产、无形资产和其他长期资产的损失-386,313.64--7,322.72
  固定资产报废损失-104,923.24-16,800.1
  公允价值变动损失--3,624,066.22--1,985,862.02
  财务费用-334,840.73-234,755.6
  投资损失--10,106,748.06--4,904,494.32
  递延所得税-131,657.34--1,273,582.67
  其中:递延所得税资产减少-131,657.34--1,273,582.67
  存货的减少-3,914,380-1,065,889.64
  经营性应收项目的减少-19,803,028.48-7,710,922.99
  经营性应付项目的增加--5,646,059.35--14,563,579.69
  其他--2,140,849.8--575,074.57
  现金的期末余额-97,434,315.63-228,873,545.78
  减:现金的期初余额-261,577,985.82-261,577,985.82
  现金及现金等价物的净增加额--164,143,670.19--32,704,440.04
公告日期2026-04-292026-04-292025-10-312025-08-30
审计意见(境内)标准无保留意见
TOP↑